In addition, a previous study indicated that RA metabolizing enzymes CYP26B1 are overexpressed significantly in colorectal cancer and that CYP26B1 is significantly associated with the prognosis of colorectal cancer patients [31]. This evidence concerns the gene CYP26B1 and colorectal cancer.